Physician profile
William Matt Collier
NPI 1750472486
$1,172.41
in general payments reported to CMS, 2019-2025
22 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $23.20 · 2022: $25.85 · 2023: $384 · 2024: $279 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $132.44 | 2019-2025 | |
| Channel Medsystems, INC. | $121.13 | 2023-2025 | |
| Hologic Sales and Service, LLC | $110.70 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Shield Therapeutics INC | $98.49 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $85.62 | 2023-2025 | Injectafer |
| Abbvie INC. | $68.78 | 2019 | |
| Exeltis, USA INC. | $67.47 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $66.47 | 2022-2024 | Veozah, Myrbetriq |
| Gynesonics, INC. | $65.90 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $61.96 | 2019-2023 | |
| Sage Therapeutics, LLC | $55.58 | 2024-2025 | Zurzuvae |
| Duchesnay USA Incorporated | $50.36 | 2019 | |
| Sumitomo Pharma America, INC. | $31.20 | 2024 | Myfembree |
| Meditrina | $25.87 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $22.04 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $20.36 | 2024 | Irrisept |
| Medtronic, INC. | $19.11 | 2025 | Interstim |
| Ethicon US, LLC | $18.79 | 2019 | |
| Organon LLC | $15.15 | 2023 | Nexplanon |
| Avion Pharmaceuticals | $12.12 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.78 | 2019 | |
| Allergan, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.